SEC Form 4 · accession 0001225208-17-004571
Edwards Lifesciences Corp · EW
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Scott B. Ullem
Officer — CVP, CFO
Period of report
Feb 22, 2017
Accepted (ET)
Feb 24, 2017 · 4:28 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001099800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Feb 22, 2017 | F | 11,815 | $89.74 | D | 34,209 | D | |
| Common StockF2 | holding | — | — | — | 42,312 | I | By Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Issuer's withholding of shares of common stock issuable upon vesting of restricted stock units to satisfy the Reporting Person's related tax withholding obligation.
- F2This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person; and it reflects 42,312 shares that were previously reported as directly held.